Semantically enabling pharmacogenomic data for the realization of personalized medicine

Matthias Samwald, Adrien Coulet, Iker Huerga, Robert L. Powers, Joanne S. Luciano, Robert Freimuth, Frederick Whipple, Elgar Pichler, Eric Prudhommeaux, Michel Dumontier, M. Scott Marshall

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Understanding how each individuals genetics and physiology influences pharmaceutical response is crucial to the realization of personalized medicine and the discovery and validation of pharmacogenomic biomarkers is key to its success. However, integration of genotype and phenotype knowledge in medical information systems remains a critical challenge. The inability to easily and accurately integrate the results of biomolecular studies with patients medical records and clinical reports prevents us from realizing the full potential of pharmacogenomic knowledge for both drug development and clinical practice. Herein, we describe approaches using Semantic Web technologies, in which pharmacogenomic knowledge relevant to drug development and medical decision support is represented in such a way that it can be efficiently accessed both by software and human experts. We suggest that this approach increases the utility of data, and that such computational technologies will become an essential part of personalized medicine, alongside diagnostics and pharmaceutical products.

Original languageEnglish (US)
Pages (from-to)201-212
Number of pages12
JournalPharmacogenomics
Volume13
Issue number2
DOIs
StatePublished - Jan 2012

Fingerprint

Precision Medicine
Pharmacogenetics
Pharmaceutical Preparations
Technology
Semantics
Information Systems
Medical Records
Software
Biomarkers
Genotype
Phenotype

Keywords

  • clinical decision support systems
  • knowledge representation
  • ontologies
  • personalized medicine
  • pharmacogenomics
  • translational medicine

ASJC Scopus subject areas

  • Pharmacology
  • Genetics
  • Molecular Medicine

Cite this

Samwald, M., Coulet, A., Huerga, I., Powers, R. L., Luciano, J. S., Freimuth, R., ... Marshall, M. S. (2012). Semantically enabling pharmacogenomic data for the realization of personalized medicine. Pharmacogenomics, 13(2), 201-212. https://doi.org/10.2217/pgs.11.179

Semantically enabling pharmacogenomic data for the realization of personalized medicine. / Samwald, Matthias; Coulet, Adrien; Huerga, Iker; Powers, Robert L.; Luciano, Joanne S.; Freimuth, Robert; Whipple, Frederick; Pichler, Elgar; Prudhommeaux, Eric; Dumontier, Michel; Marshall, M. Scott.

In: Pharmacogenomics, Vol. 13, No. 2, 01.2012, p. 201-212.

Research output: Contribution to journalArticle

Samwald, M, Coulet, A, Huerga, I, Powers, RL, Luciano, JS, Freimuth, R, Whipple, F, Pichler, E, Prudhommeaux, E, Dumontier, M & Marshall, MS 2012, 'Semantically enabling pharmacogenomic data for the realization of personalized medicine', Pharmacogenomics, vol. 13, no. 2, pp. 201-212. https://doi.org/10.2217/pgs.11.179
Samwald, Matthias ; Coulet, Adrien ; Huerga, Iker ; Powers, Robert L. ; Luciano, Joanne S. ; Freimuth, Robert ; Whipple, Frederick ; Pichler, Elgar ; Prudhommeaux, Eric ; Dumontier, Michel ; Marshall, M. Scott. / Semantically enabling pharmacogenomic data for the realization of personalized medicine. In: Pharmacogenomics. 2012 ; Vol. 13, No. 2. pp. 201-212.
@article{feabc55c33454d25b8a169becddf6302,
title = "Semantically enabling pharmacogenomic data for the realization of personalized medicine",
abstract = "Understanding how each individuals genetics and physiology influences pharmaceutical response is crucial to the realization of personalized medicine and the discovery and validation of pharmacogenomic biomarkers is key to its success. However, integration of genotype and phenotype knowledge in medical information systems remains a critical challenge. The inability to easily and accurately integrate the results of biomolecular studies with patients medical records and clinical reports prevents us from realizing the full potential of pharmacogenomic knowledge for both drug development and clinical practice. Herein, we describe approaches using Semantic Web technologies, in which pharmacogenomic knowledge relevant to drug development and medical decision support is represented in such a way that it can be efficiently accessed both by software and human experts. We suggest that this approach increases the utility of data, and that such computational technologies will become an essential part of personalized medicine, alongside diagnostics and pharmaceutical products.",
keywords = "clinical decision support systems, knowledge representation, ontologies, personalized medicine, pharmacogenomics, translational medicine",
author = "Matthias Samwald and Adrien Coulet and Iker Huerga and Powers, {Robert L.} and Luciano, {Joanne S.} and Robert Freimuth and Frederick Whipple and Elgar Pichler and Eric Prudhommeaux and Michel Dumontier and Marshall, {M. Scott}",
year = "2012",
month = "1",
doi = "10.2217/pgs.11.179",
language = "English (US)",
volume = "13",
pages = "201--212",
journal = "Pharmacogenomics",
issn = "1462-2416",
publisher = "Future Medicine Ltd.",
number = "2",

}

TY - JOUR

T1 - Semantically enabling pharmacogenomic data for the realization of personalized medicine

AU - Samwald, Matthias

AU - Coulet, Adrien

AU - Huerga, Iker

AU - Powers, Robert L.

AU - Luciano, Joanne S.

AU - Freimuth, Robert

AU - Whipple, Frederick

AU - Pichler, Elgar

AU - Prudhommeaux, Eric

AU - Dumontier, Michel

AU - Marshall, M. Scott

PY - 2012/1

Y1 - 2012/1

N2 - Understanding how each individuals genetics and physiology influences pharmaceutical response is crucial to the realization of personalized medicine and the discovery and validation of pharmacogenomic biomarkers is key to its success. However, integration of genotype and phenotype knowledge in medical information systems remains a critical challenge. The inability to easily and accurately integrate the results of biomolecular studies with patients medical records and clinical reports prevents us from realizing the full potential of pharmacogenomic knowledge for both drug development and clinical practice. Herein, we describe approaches using Semantic Web technologies, in which pharmacogenomic knowledge relevant to drug development and medical decision support is represented in such a way that it can be efficiently accessed both by software and human experts. We suggest that this approach increases the utility of data, and that such computational technologies will become an essential part of personalized medicine, alongside diagnostics and pharmaceutical products.

AB - Understanding how each individuals genetics and physiology influences pharmaceutical response is crucial to the realization of personalized medicine and the discovery and validation of pharmacogenomic biomarkers is key to its success. However, integration of genotype and phenotype knowledge in medical information systems remains a critical challenge. The inability to easily and accurately integrate the results of biomolecular studies with patients medical records and clinical reports prevents us from realizing the full potential of pharmacogenomic knowledge for both drug development and clinical practice. Herein, we describe approaches using Semantic Web technologies, in which pharmacogenomic knowledge relevant to drug development and medical decision support is represented in such a way that it can be efficiently accessed both by software and human experts. We suggest that this approach increases the utility of data, and that such computational technologies will become an essential part of personalized medicine, alongside diagnostics and pharmaceutical products.

KW - clinical decision support systems

KW - knowledge representation

KW - ontologies

KW - personalized medicine

KW - pharmacogenomics

KW - translational medicine

UR - http://www.scopus.com/inward/record.url?scp=84855963774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855963774&partnerID=8YFLogxK

U2 - 10.2217/pgs.11.179

DO - 10.2217/pgs.11.179

M3 - Article

C2 - 22256869

AN - SCOPUS:84855963774

VL - 13

SP - 201

EP - 212

JO - Pharmacogenomics

JF - Pharmacogenomics

SN - 1462-2416

IS - 2

ER -